Meeting
2012 ASCO Annual Meeting
Regional screening network for characterization of the molecular epidemiology of non-small cell lung cancer (NSCLC) and implementation of personalized treatment.
Authors
Thomas Zander
Lung Cancer Group Cologne, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany
Thomas Zander , Lukas Carl Heukamp , Marc Christiaan Allardt Bos , Jana Fassunke , Christian Mattonet , Sabine Merkelbach-Bruse , Yon-Dschun Ko , Andreas Schlesinger , Michael Brockmann , Monika Serke , Ulrich Gerigk , Khosro Hekmat , Walburga Engel-Riedel , Erich Stoelben , Marcel Reiser , Holger Schulz , Stephan H. Schmitz , Konrad Frank , Reinhard Buettner , Juergen Wolf
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Genomic and Epigenomic Biomarkers
Citation
J Clin Oncol 30, 2012 (suppl; abstr CRA10529)
DOI
10.1200/jco.2012.30.15_suppl.cra10529
Abstract #
CRA10529
Poster Bd #
22
Abstract Disclosures
Similar Posters
Poster
2012 ASCO Annual Meeting
Frequency and clinical characterization of NSCLC patients harboring PIK3CA mutations identified within a regional screening network.
First Author: Masyar Gardizi
Poster
2023 ASCO Annual Meeting
A nation-wide genomic screening project for further development of targeted therapies in treatment-refractory non–small-cell lung cancer (LC-SCRUM-TRY).
First Author: Hiroki Izumi
Poster
2018 ASCO Annual Meeting
Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.
First Author: Takashi Seto
Poster
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
First Author: Matthias Scheffler